Plasminogen activator inhibitor-1 controls bone marrow-derived cells therapeutic effect through MMP9 signaling: Role in physiological and pathological wound healing

Stem Cells

Volumn 30, Issue 7, 2012, Pages 1436-1446

  Ebrahimian, Teni G ^a   Squiban, Claire ^a   Roque, Telma ^a   Lugo Martinez, Haydee ^a   Hneino, Mohamad ^a   Buard, Valerie ^a   Gourmelon, Patrick ^a   Benderitter, Marc ^a   Milliat, Fabien ^a   Tamarat, Radia ^a  

^a INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE IRSN   (France)

Author keywords

Bone marrow; Metalloproteinase; Plasminogen activator inhibitors; Radiation; Wound healing

Indexed keywords

GELATINASE B; LECTIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; SCATTER FACTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TRANSPLANTATION; CONTROLLED STUDY; IN VITRO STUDY; IRRADIATION; MALE; MOUSE; NONHUMAN; PLASMA SKIN REGENERATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SKIN BLOOD FLOW; STEM CELL MOBILIZATION; UPREGULATION; WOUND CLOSURE; WOUND HEALING;

ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; MALE; MATRIX METALLOPROTEINASE 9; MICE; MICE, KNOCKOUT; PLASMINOGEN ACTIVATOR INHIBITOR 1; WOUND HEALING;

ANIMALIA; MUS;

EID: 84862885708     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.1126     Document Type: Article

References (34)

1. Risau W. Mechanisms of angiogenesis. Nature 1997;386:671-674. (Pubitemid 27193480)
2. Carmeliet P. Angiogenesis in health and disease. Nat Med 2003;9:653-660. (Pubitemid 36749213)
3. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002;2:161-174. (Pubitemid 37328786)
4. Makela M, Larjava H, Pirila E et al. Matrix metalloproteinase 2 (gelatinase A) is related to migration of keratinocytes. Exp Cell Res 1999;251:67-78. (Pubitemid 29406520)
5. Waselenko JK, MacVittie TJ, Blakely WF et al. Medical management of the acute radiation syndrome: Recommendations of the Strategic National Stockpile Radiation Working Group. Ann Intern Med 2004;140:1037-1051.
6. Burdelya LG, Krivokrysenko VI, Tallant TC et al. An agonist of toll-like receptor 5 has radioprotective activity in mouse and primate models. Science 2008;320:226-230. (Pubitemid 351521417)
7. Jost M, Maillard C, Lecomte J et al. Tumoral and choroidal vascularization: Differential cellular mechanisms involving plasminogen activator inhibitor type I. Am J Pathol 2007;171:1369-1380. (Pubitemid 47582909)
8. Chan JC, Duszczyszyn DA, Castellino FJ et al. Accelerated skin wound healing in plasminogen activator inhibitor-1-deficient mice. Am J Pathol 2001;159:1681-1688. (Pubitemid 33062511)
9. Romer J, Bugge TH, Pyke C et al. Plasminogen and wound healing. Nat Med 1996;2:725.
10. Bugge TH, Kombrinck KW, Flick MJ et al. Loss of fibrinogen rescues mice from the pleiotropic effects of plasminogen deficiency. Cell 1996;87:709-719. (Pubitemid 26386944)
11. van Hinsbergh VW, Engelse MA, Quax PH. Pericellular proteases in angiogenesis and vasculogenesis. Arterioscler Thromb Vasc Biol 2006;26:716-728. (Pubitemid 43732143)
12. Lund LR, Romer J, Bugge TH et al. Functional overlap between two classes of matrix-degrading proteases in wound healing. EMBO J 1999;18:4645-4656. (Pubitemid 29415519)
13. Borue X, Lee S, Grove J et al. Bone marrow-derived cells contribute to epithelial engraftment during wound healing. Am J Pathol 2004;165:1767-1772. (Pubitemid 39435173)
14. Ebrahimian TG, Pouzoulet F, Squiban C et al. Cell therapy based on adipose tissue-derived stromal cells promotes physiological and pathological wound healing. Arterioscler Thromb Vasc Biol 2009;29:503-510.
15. Tamarat R, Silvestre JS, Le Ricousse-Roussanne S et al. Impairment in ischemia-induced neovascularization in diabetes: Bone marrow mononuclear cell dysfunction and therapeutic potential of placenta growth factor treatment. Am J Pathol 2004;164:457-466. (Pubitemid 38364662)
16. Planat-Benard V, Silvestre JS, Cousin B et al. Plasticity of human adipose lineage cells toward endothelial cells: Physiological and therapeutic perspectives. Circulation 2004;109:656-663. (Pubitemid 38198874)
17. Tamarat R, Silvestre JS, Durie M et al. Angiotensin II angiogenic effect in vivo involves vascular endothelial growth factor- and inflammation-related pathways. Lab Invest 2002;82:747-756. (Pubitemid 34633824)
18. Ebrahimian TG, Heymes C, You D et al. NADPH oxidase-derived overproduction of reactive oxygen species impairs postischemic neovascularization in mice with type 1 diabetes. Am J Pathol 2006;169:719-728. (Pubitemid 44156327)
19. Foubert P, Matrone G, Souttou B et al. Coadministration of endothelial and smooth muscle progenitor cells enhances the efficiency of proangiogenic cell-based therapy. Circ Res 2008;103:751-760.
20. Foubert P, Silvestre JS, Souttou B et al. PSGL-1-mediated activation of EphB4 increases the proangiogenic potential of endothelial progenitor cells. J Clin Invest 2007;117:1527-1537. (Pubitemid 46871337)
21. Bergers G, Brekken R, McMahon G et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2000;2:737-744.
22. Heissig B, Hattori K, Dias S et al. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 2002;109:625-637. (Pubitemid 34628725)
23. Bajou K, Masson V, Gerard RD et al. The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies. J Cell Biol 2001;152:777-784. (Pubitemid 34280162)
24. Lyden D, Hattori K, Dias S et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 2001;7:1194-1201. (Pubitemid 33063774)
25. van den Brenk HA, Sharpington C, Orton C et al. Effects of x-radiation on growth and function of the repair blastema (granulation tissue). II. Measurements of angiogenesis in the Selye pouch in the rat. Int J Radiat Biol Relat Stud Phys Chem Med 1974;25:277-289.
26. Barkho BZ, Munoz AE, Li X et al. Endogenous matrix metalloproteinase (MMP)-3 and MMP-9 promote the differentiation and migration of adult neural progenitor cells in response to chemokines. Stem Cells 2008;26:3139-3149.
27. Copland IB, Lord-Dufour S, Cuerquis J, Coutu DL, Annabi B, Wang E, Galipeau J. Improved autograft survival of mesenchymal stromal cells by plasminogen activator inhibitor 1 inhibition. Stem Cells 2009;27:467-477.
28. Bernstein EF, Sullivan FJ, Mitchell JB et al. Biology of chronic radiation effect on tissues and wound healing. Clin Plast Surg 1993;20:435-453. (Pubitemid 23173096)
29. Doyle JW, Li YQ, Salloum A et al. The effects of radiation on neovascularization in a rat model. Plast Reconstr Surg 1996;98:129-135; discussion 136-129.
30. Zhao W, Spitz DR, Oberley LW et al. Redox modulation of the profibrogenic mediator plasminogen activator inhibitor-1 following ionizing radiation. Cancer Res 2001;61:5537-5543. (Pubitemid 32694939)
31. Hageman J, Eggen BJ, Rozema T et al. Radiation and transforming growth factor-beta cooperate in transcriptional activation of the profibrotic plasminogen activator inhibitor-1 gene. Clin Cancer Res 2005;11:5956-5964. (Pubitemid 41170326)
32. Oikawa T, Freeman M, Lo W et al. Modulation of plasminogen activator inhibitor-1 in vivo: A new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition. Kidney Int 1997;51:164-172. (Pubitemid 27064534)
33. Vozenin-Brotons MC, Milliat F, Linard C et al. Gene expression profile in human late radiation enteritis obtained by high-density cDNA array hybridization. Radiat Res 2004;161:299-311. (Pubitemid 40797072)
34. Milliat F, Sabourin JC, Tarlet G et al. Essential role of plasminogen activator inhibitor type-1 in radiation enteropathy. Am J Pathol 2008;172:691-701. (Pubitemid 351354542)